Sage Medical Hub | Information for Medical Professionals

On October 31st, 2023, the U.S. Drug Enforcement Administration (DEA) placed ZURZUVAE™ (zuranolone) in Schedule IV of the Controlled Substances Act (CSA). For more information, please see the Full Prescribing Information, including Boxed WARNING, and Medication Guide for ZURZUVAE.

Sage Medical Hub

Welcome to the

Sage Medical Hub

Search our library of medical resources to learn more about our disease states, products, and pipeline.

Search the Sage Medical Library

Select a Product or Compound^*

Search by Keyword^*

Scientific Response Letters

Congress Presentations

Journal Publications

^* Indicates a required field

Talk with a Sage Medical Representative

Call 833-574-7243
Monday-Friday 9am-5pm EST

Submit a Medical Inquiry

Schedule a Meeting with a Medical Science Liaison (MSL)

Explore the Sage Medical Hub

Product Information

Search for evidence-based clinical and scientific data about Sage approved products and compounds

Publications & Congresses

Access Sage-sponsored clinical trial data in peer-reviewed journals and congress presentations

Funding & Giving

Learn how Sage supports people and organizations with the goal of creating positive and lasting change

Formatted Data

Upcoming Events Learn about upcoming events

See All Events

to

For US Healthcare Professionals only

TO REPORT AN ADVERSE EVENT OR PRODUCT COMPLAINT PLEASE CALL 844-4-SAGERX

TO REPORT AN ADVERSE EVENT OR PRODUCT COMPLAINT PLEASE CALL 844-4-SAGERX